I just can't understand how RHY can sell COLOSTAT in the near to medium term
Not published in medial journals that I am aware of
Not recognised/mentioned by any scientists outside of RHY
Not presenting at Australian conferences to showcase COLOSTAT
Not presenting at World conferences to showcase COLOSTAT
No disclosure of sensitivity and specificity for all stages of cancer
No disclosure of sensitivity and specificity for advanced adenomas
Just because RHY has found 2 manufacturing (micro caps) to make the COLOSTAT test kit doesn't mean it will produce them. A lot of water needs to go under the bridge.
FirstSight is not quite ready for commercialisation but far more advanced than RHY with everything they do. They were going down the path of CLIA but due to above average results they are now pursuing the FDA route. This will 100% ensure medicare/medicaid reimburesment.
It will sell for under $200.
Before you say that blood-based testing requires basically NO capital investment, any capital investment and training for a superior product will have a very quick pay off.
Whether these CRC blood testing companies around the world start selling in Australia is anyone's guess.
https://www.medindia.net/health-press-release/cellmax-life-announces-positive-results-from-prospective-multisite-study-of-novel-blood-test-to-detect-colorectal-cancer-and-pre--615923-1.htm
https://www.prweb.com/releases/2023/1/prweb19120238.htm
https://cellmaxlife.com/
- Forums
- ASX - By Stock
- RHY
- CellMax Life's FirstSight CRC Blood Test (DNA)
CellMax Life's FirstSight CRC Blood Test (DNA)
-
- There are more pages in this discussion • 17 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RHY (ASX) to my watchlist
(20min delay)
|
|||||
Last
7.6¢ |
Change
0.000(0.00%) |
Mkt cap ! $18.89M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 215025 | 7.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
8.0¢ | 13055 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 1439 | 0.066 |
1 | 17000 | 0.065 |
2 | 40000 | 0.063 |
1 | 17085 | 0.062 |
1 | 5000 | 0.061 |
Price($) | Vol. | No. |
---|---|---|
0.080 | 13055 | 2 |
0.083 | 7260 | 1 |
0.084 | 43251 | 2 |
0.085 | 17407 | 1 |
0.091 | 161352 | 1 |
Last trade - 16.12pm 04/10/2024 (20 minute delay) ? |
Featured News
LU7
Discover the strong preliminary feasibility of the Bécancour Lithium Refinery, showcasing resilience in a low pricing environment and a strategic plan to capitalize on future price recoveries
RHY (ASX) Chart |
Day chart unavailable